The pharmaceutical giant AstraZeneca has scrapped plans for a £450m expansion of its childhood flu vaccine manufacturing site in Speke, Merseyside, following protracted negotiations with the UK government over state
The pharmaceutical giant AstraZeneca has scrapped plans for a £450m expansion of its childhood flu vaccine manufacturing site in Speke, Merseyside, following protracted negotiations with the UK government over state






